Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis.
Ibrutinib-related hypertension associated with increased risk for major adverse cardiovascular events.
Identifying progressive anemia and thrombocytopenia in patients with PV or ET may be predictive of MPN progression to secondary myelofibrosis.
Community oncologists help refer appropriate patients to authorized treatment centers.
Reduced pain but worsening of neuropathy seen for IxaThalDex induction therapy in relapsed/refractory multiple myeloma.
U.S. Department of Health and Human Services issues guidance to help doctors taper patients safely.
Portal users more likely to be younger, white, have commercial insurance, higher annual income.
A retrospective cohort study explored outcomes for pregnant women with HL who received antenatal chemotherapy compared with a match cohort of nonpregnant women.
Minorities more likely to report difficulty seeing a culturally similar health care provider.
Findings support expansion of genetic testing to all women with breast cancer.
Researchers examined treatment patterns and prognostic factors in male breast cancer.
In the TITAN trial, health-related quality of life did not worsen with the addition of apalutamide to ADT versus placebo for patients with metastatic castration-sensitive prostate cancer.
Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.
A retrospective analysis of more than 7000 patients found a potential association between colorectal cancer, hepatic metastasis, and chronic HBV status.
Bill would restrict nicotine content to a maximum of 20 mg/mL.